Tubeless Strategy for Enhanced Recovery After Sublobar Resection
NCT07409129
Early Stage Lung Cancer (I and II), Lung Diseases
Guangzhou, China
View Trial DetailsNCT Number: NCT06737107
The study is a retrospective, observational and multicentric study. The study describes robotic segmentectomies performed in four referred centers, with the aim to assess the perioperative compilications of robotic segmentectomies compared to video-assisted thoracoscopic surgery (VATS) and open approach.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Istituto Clinico Humanitas, Rozzano, Milan, Italy
Minimally invasive techniques have been gradually replacing open approach in the treatment of lung cancer. Video-assisted thoracoscopic surgery (VATS) was the first procedure to be developed in the thoracic field and is the most widespread. It has been associated with decreased postoperative pain, shorter recovery, decreased inflammatory response and improved tolerance to chemotherapy.
What is limiting video-assisted thoracoscopic surgery (VATS) spread is the steep learning curve, difficulties and discomfort to operate, suboptimal view and rigid instrumentation. These problems have been partially overcome by the Robotic technique (RATS).
This study aims to compare the perioperative complications of robotic segmentectomies to VATS and open approaches.
In addition, The secondary aim of the study is to analyze the duration of surgery, mediastinal and hilar lymph nodes dissection, rate of conversion of robotic approach compared to VATS, overall survival and disease free survival in the three different approaches.
The study is retrospective, observational and multicentric. The four centers involved are: IRCCS San Raffaele Hospital, IRCCS European Institute of Oncology - IEO, IRCCS Humanitas Research Hospital - ICH and the department of General Thoracic Surgery, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
The population includes: all patients that underwent segmentectomies from the 1st January 2010 to the 31st of December 2023 treated with robotic segmentectomy and VATS or open segmentectomy, reaching a total of 472 cases of which 50 from our hospital.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from the surgery at 30-90 days after
The investigators will measure the perioperative complications of robotic lung resection in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC).
Complications will be categorized according to the Clavien-Dindo scale.
Time frame: 30-90 days after surgery
The investigators will measure the perioperative complications of video-assisted thoracoscopic surgery (VATS) appraoch in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC).
Complications will be categorized according to the Clavien-Dindo scale.
Time frame: 30-90 days after surgery
The investigators will measure the perioperative complications of open approach in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.
Time frame: up to 1 month
Duration of the surgery based on the approach measured in minutes
Time frame: up to 1 month
Number of lymphonodes station resected
Time frame: up to 1 month
Number of surgery procedures converted
Time frame: up to 5 years
Presence or absence of local and distant relapse
Contact information is provided by the study sponsor or research team.
Scientific Institute San Raffaele
Other
Anatomical Segmentectomies for Early Stage Lung Cancer. A Multicenter Analysis of RATS, VATS and Open Approach
Acronym: ANASEGME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07409129
Early Stage Lung Cancer (I and II), Lung Diseases
Guangzhou, China
View Trial DetailsNCT07489066
Bronchial Neoplasms, Carcinoma
Hinsdale, Illinois, United States
View Trial DetailsNCT07659782
Bronchial Neoplasms, Carcinoma, Bronchogenic
Los Angeles, California, United States
View Trial DetailsNCT05267626
Adenocarcinoma, Advanced Solid Tumor
Miami, Florida, United States
View Trial Details